Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Carlsson

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Urology|September 30, 2024
Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate CancerJose M Flores, Emily A Vertosick, Carolyn A Salter, et al.
Urologic Oncology|March 21, 2025
Convalescence after radical orchiectomy: Detailing surgical recovery with a novel electronic patient reported outcome (ePRO) platformSamuel A Gold, Viranda H Jayalath, Rebecca Yu, et al.
Urologic Oncology|December 10, 2016
Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinomaAndrew G Winer, Emily A Vertosick, Mazyar Ghanaat, et al.
European Urology|January 14, 2014
A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortalityMarco Zappa, Donella Puliti, Jonas Hugosson, et al.
The Journal of Urology|April 1, 2022
Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerMarlon Perera, Melissa J Assel, Nicole E Benfante, et al.
JCO Oncology Practice|July 1, 2026
Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer SurgeryJennifer R Cracchiolo, Richard S Matulewicz, Norma E Farrow, et al.
Urologic Oncology|April 21, 2020
Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesionsBashir Al Hussein Al Awamlh, Leonard S Marks, Geoffrey A Sonn, et al.
The Journal of Urology|October 9, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|March 19, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|January 8, 2020
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Urology|September 30, 2024
Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate CancerJose M Flores, Emily A Vertosick, Carolyn A Salter, et al.
Urologic Oncology|March 21, 2025
Convalescence after radical orchiectomy: Detailing surgical recovery with a novel electronic patient reported outcome (ePRO) platformSamuel A Gold, Viranda H Jayalath, Rebecca Yu, et al.
Urologic Oncology|December 10, 2016
Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinomaAndrew G Winer, Emily A Vertosick, Mazyar Ghanaat, et al.
European Urology|January 14, 2014
A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortalityMarco Zappa, Donella Puliti, Jonas Hugosson, et al.
The Journal of Urology|April 1, 2022
Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerMarlon Perera, Melissa J Assel, Nicole E Benfante, et al.
JCO Oncology Practice|July 1, 2026
Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer SurgeryJennifer R Cracchiolo, Richard S Matulewicz, Norma E Farrow, et al.
Urologic Oncology|April 21, 2020
Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesionsBashir Al Hussein Al Awamlh, Leonard S Marks, Geoffrey A Sonn, et al.
The Journal of Urology|October 9, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|March 19, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|January 8, 2020
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
Pageof 10